In re: Jaspreet Kaur Attariwala v. Bioconvergence LLC

CourtUnited States Bankruptcy Court, District of Columbia
DecidedApril 29, 2026
Docket20-10009
StatusUnknown

This text of In re: Jaspreet Kaur Attariwala v. Bioconvergence LLC (In re: Jaspreet Kaur Attariwala v. Bioconvergence LLC) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re: Jaspreet Kaur Attariwala v. Bioconvergence LLC, (D.C. 2026).

Opinion

order below is hereby signed. So April 29 2026 ” eee” a LACE — i TOF ou CLE a pecan me Elizabeth iL. Gu 1 (US. Bankru pty Judge

UNITED STATES BANKRUPTCY COURT DISTRICT OF COLUMBIA In re: Jaspreet Kaur Attariwala, Case No. 19-00828-ELG Debtor. Chapter 13 Bioconvergence LLC, Adv. Pro. 20-10009-ELG Plaintiff, v. Jaspreet Kaur Attariwala, Defendant.

MEMORANDUM OPINION ON MOTION FOR SUMMARY JUDGMENT Before the Court are the Motion for Summary Judgment (the “Motion”) filed by Bioconvergence LLC d/b/a Singota Solutions (the “Plaintiff’), the Opposition filed by Jaspreet Kaur Attariwala (the “Debtor’”), and the Plaintiff's Reply.! Upon consideration of the pleadings, the arguments of counsel at the hearing held on June 26, 2025, and for the reasons set forth herein, the Court grants the Motion. I. Jurisdiction and Standard The Court has jurisdiction over this matter pursuant to 28 U.S.C. 8§ 157 and 1334. This is a core proceeding pursuant to 28 U.S.C. § 157(b)(2)(). Venue is proper before the Court pursuant to 28 U.S.C. §§ 1408 and 1409. This Memorandum Opinion sets forth the Court’s findings of fact

' See Mot. Summ. J., ECF No. 34; Mem. of P. & A. in Supp. of Mot. Summ. J., ECF No. 34-1; Opp’n to Mot. of Bioconvergence LLC d/b/a Singota Solutions for Summ. J., ECF No. 39; Reply in Supp. of Mot. Summ. J., ECF No. AO.

and conclusions of law in accordance with Bankruptcy Rule 7052.2 Findings of fact shall be construed as conclusions of law and conclusions of law shall be construed as findings of fact where appropriate.3 Summary judgment is proper where “the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law.”4 A fact is material where it might affect the outcome of the suit under the governing law, and a dispute is genuine if resolution thereof could establish an element of a claim or defense and, therefore, affect the outcome of the action.5 When evaluating a motion for summary judgment, the court must draw all reasonable inferences in favor of the non-moving party and accept the non-moving party’s evidence as true.6 The movant has the burden of showing that there is no genuine issue of fact and they are entitled to judgment as a matter of law.7 II. Uncontested Facts8 A. Pre-Litigation Conduct The Plaintiff first employed the Debtor as a Senior Business Development Manager in September 2015.9 Effective September 28, 2015, the parties executed an employment agreement

2 Unless specifically indicated otherwise, all section references are to Title 11 of the United States Code (the “Bankruptcy Code”). The Federal Rules of Bankruptcy Procedure shall be referred to as the “Bankruptcy Rules,” and the Federal Rules of Civil Procedure shall be referred to as the “Civil Rules” herein. 3 Fed. R. Bankr. P. 7052. 4 Fed. R. Civ. P. 56(c) (made applicable to this adversary proceeding by Fed. R. Bankr. P. 7056); Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986). 5 Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248 (1986); see Celotex, 477 U.S. at 322. 6 See Ricci v. DeStefano, 557 U.S. 557, 586 (2009); Scott v. Harris, 550 U.S. 372, 380 (2007); Evans v. Sebelius, 716 F.3d 617, 619 (D.C. Cir. 2013). 7 Celotex, 477 U.S. at 323; Beck v. Test Masters Educ. Servs., 994 F. Supp. 2d 90, 94 (D.D.C. 2013). 8 As discussed infra, the United States District Court for the Southern District of Illinois held a multi-day bench trial in the case of Bioconvergence LLC v. Attariwala and issued two memorandum decisions and a judgment in favor of Plaintiff. Findings of Fact and Conclusions of Law Following Bench Trial, Bioconvergence LLC v. Attariwala, No. 1:19-cv-01745-SEB-MG (S.D. Ind. Dec. 21, 2023), ECF No. 603 [hereinafter Findings of Fact]; Order on Damages, Att’y Fees, Litigation Expenses, and Costs, Bioconvergence LLC v. Attariwala, No. 1:19-cv-01745-SEB-MG (S.D. Ind. Mar. 26, 2024), ECF No. 613; Inj. and Final J., Bioconvergence LLC v. Attariwala, No. 1:19-cv-01745-SEB-MG (S.D. Ind. Mar. 26, 2024), ECF No. 614. Because there has been a trial on the merits, and because the Debtor does not contest the findings (factual or legal), the Court may rely thereon as undisputed facts for the purposes of the pending Motion. Opp’n to Mot. of Bioconvergence LLC d/b/a Singota Solutions for Summ. J., ECF No. 39, at 1. 9 Findings of Fact, supra note 8, at 2–4. (the “Employment Agreement”) in which the Debtor agreed to neither solicit certain clients and prospective clients of the Plaintiff, nor to transmit, provide, or copy the Plaintiff’s confidential information (the “Confidential Information”), which was defined in the Employment Agreement to include: [A]ny proprietary, confidential, or company-sensitive information and materials which are the property of or relate to the [Plaintiff] or business of the [Plaintiff]. Confidential Information shall include without limitation all information and materials created by, provided to, or otherwise disclosed to [the Debtor] in connection with [the Debtor]’s employment with the [Plaintiff] (excepting only information and materials already known by the general public), including without limitation (i) trade secrets, (ii) the names and addresses of the [Plaintiff]’s past, present or prospective contributors, beneficiaries or business contacts, and all information relating to such contributors, beneficiaries, or business contacts, regardless of whether such information was supplied or produced by the [Plaintiff] or such contributors, beneficiaries, or business contacts; and (iii) information concerning the [Plaintiff]’s affiliates, financing sources, profits, revenues, financial condition, fund raising activity, and investment activity, business strategies, and software used by the [Plaintiff] and associated layouts, templates, processes, documentation, databases, designs, and techniques.10

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Miller v. J.D. Abrams Inc. (In Re Miller)
156 F.3d 598 (Fifth Circuit, 1998)
Moore v. United States
160 U.S. 268 (Supreme Court, 1895)
Allen v. McCurry
449 U.S. 90 (Supreme Court, 1980)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Grogan v. Garner
498 U.S. 279 (Supreme Court, 1991)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Taylor v. Sturgell
553 U.S. 880 (Supreme Court, 2008)
Ricci v. DeStefano
557 U.S. 557 (Supreme Court, 2009)
Harold Martin v. Department of Justice
488 F.3d 446 (D.C. Circuit, 2007)
Vernard Evans v. Kathleen Sebelius
716 F.3d 617 (D.C. Circuit, 2013)
Gore v. Kressner (In Re Kressner)
155 B.R. 68 (S.D. New York, 1993)
Johnson v. Davis (In Re Davis)
262 B.R. 663 (E.D. Virginia, 2001)
Brown v. Brown (In Re Brown)
331 B.R. 243 (W.D. Virginia, 2005)
Rountrey v. Lee (In Re Lee)
90 B.R. 202 (E.D. Virginia, 1988)

Cite This Page — Counsel Stack

Bluebook (online)
In re: Jaspreet Kaur Attariwala v. Bioconvergence LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-jaspreet-kaur-attariwala-v-bioconvergence-llc-dcb-2026.